AI chatbots misdiagnose in over 80% of early medical cases, study finds
80%+ misdiagnosis rate. AI chatbots are rushing to judgment on incomplete patient data—and healthcare leaders need to know before deployment.
Why it matters
A peer-reviewed study on AI safety and reliability in high-stakes medical domains exposes a critical governance gap: major LLM providers haven't adequately validated their models for clinical use. This is the kind of regulatory/ethics story that will shape enterprise AI procurement and liability frameworks.
The key facts
5 to knowOver 80% misdiagnosis rate in early medical cases
Models tested: OpenAI and DeepSeek flagged for rapid judgments on incomplete data
Issue: LLMs making clinical decisions without sufficient guardrails or validation
Published by Financial Times (credible source)
Implications for healthcare AI deployment and liability
Go to the source
Financial Times Technologyft.com
Publisher excerpt: Top models including OpenAI and DeepSeek make judgments too quickly when patient data is incomplete